MENU
HURA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
TuHURA Biosciences (HURA) Ownership - Who owns TuHURA Biosciences?
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy... Show more
Profile
Industry
N/A
Address
10500 University Center Drive
Phone
+1 813 875-6600
Employees
N/A
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
96.97M
P/E Ratio
N/A
Total Cash
6.22M
Projected Growth
N/A
Total Debt
164.59K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.14
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
HURA
Capitalization
97M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
6.22M
Total Cash/Share
0.14
Total Debt
165K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
9.58M
P/B Ratio
10.12
Cash Flow
N/A
Earnings
-0.96
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
43.7K
Current Ratio
3.00
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-19.52M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-239.65
Shares Held By Institutions
13.2M
Shares Outstanding - Current
43.7M
Total Liabilities
4.78M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-45.721
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
10500 University Center Drive
Phone
+1 813 875-6600
Employees
N/A
Web
N/A